Contact us

CRO

Our Belief: Research is the foundation of sustained growth in pharmaceuticals which is why R&D is always at the heart of CVR Life Sciences.
We are a specialized partner to the pharmaceutical industries, providing end-to-end support in drug development with regulatory compliance. Thus enabling our customers to accelerate innovation, reduce costs, and bring life-saving medicines to market faster.

We are aspecialized partner to the pharmaceutical and biotechnology industries, providing end-to-end support in drug development, clinical trials, and regulatory compliance. Thus enabling our customers to accelerate innovation, reduce costs, and bring life-saving medicines to market faster.

CVR Lifesciences combines scientific innovation, regulatory compliance, and cost-effective manufacturing to position itself as a trusted partner in the global pharmaceutical supply chain.

Capabilities

  • Advanced R&D Infrastructure: Equipped with modern labs and led by experienced scientists and chemists.
  • Route Scouting & Yield Improvement: Expertise in developing efficient synthetic routes for APIs, reducing stages, and improving yields.
  • Generic API Development: Supplying cost-effective, high-quality APIs to global markets.
  • Technology Implementation: Adopting new technologies for process optimization and compliance.
  • NCE-1 Molecule Development: Working on novel chemical entities with selective principles.
  • Quality by Design (QbD): Ensuring sustainable synthetic routes based on SELECT principles (Safety, Environment, Legal, Economics, Control, Throughput).
  • Specialized Chemistry: Multistep synthesis, alkylations, asymmetric synthesis, and other advanced processes.

R&D Excellence

  • Expertise in Robust process development, and technology transfer for Active Pharmaceutical Ingredients (APIs) and intermediates.
  • Implementation of structured quality risk assessments throughout the development lifecycle.
  • Fully equipped analytical laboratory featuring HPLC, GC, LC-MS/MS, and other advanced instrumentation.
  • Comprehensive evaluation and control strategies for genotoxic and nitrosamine impurities.
  • Strategic Intellectual property management and design of non-infringing synthetic routes for generics.
  • Pilot-scale capabilities with reactors ranging from 60L to 250L for proof-of-concept and scale-up studies.
  • Compliance with current Good Laboratory Practice (cGLP) and current Good Manufacturing Practice (cGMP) standards;
    preparation of Drug Master File (DMF) documentation tailored to Global regulatory requirements.

►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None